Literature DB >> 9384886

The role of psychotherapy in the treatment of substance-use disorders.

L M Najavits1, R D Weiss.   

Abstract

Psychotherapies for substance-use disorders are reviewed, with particular attention to modifications of standard treatments necessary to make them effective for patients with disorders. Treatments reviewed include cognitive-behavioral therapies (Relapse Prevention, Cognitive Therapy, Contingency Contracting, Behavioral Treatment, Cue Exposure, Network Therapy, and Aversion Therapy) and psychodynamic/interpersonal methods (Supportive-Expressive Therapy, Interpersonal Therapy, Motivational Interviewing, and Modified Psychoanalytic Therapy). The psychotherapies selected are individual, verbally based treatments for substance-use disorders; except for modified psychoanalytic therapy, all have been presented in treatment manuals and empirically studied. Research shows that these forms of psychotherapy can be effective, with some treatments providing more benefit than others for specific subpopulations, but no one treatment is consistently more effective than any other. General guidelines consistent across psychotherapies for substance-use disorders are discussed, with emphasis on phases of treatment, the importance of a compassionate stance by the therapist, the difficulty of engaging substance abusers in treatment, the need for urine and breath-alcohol testing, assessment of comorbid disorders, countertransference problems, the need for multiple treatment modalities, evaluation of the therapist's effectiveness, adjusting the amount of treatment, and appropriate termination. Directions for future research are also discussed.

Entities:  

Mesh:

Year:  1994        PMID: 9384886     DOI: 10.3109/10673229409017121

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  6 in total

1.  How to design an effective treatment outcome study.

Authors:  Lisa M Najavits
Journal:  J Gambl Stud       Date:  2003

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Addiction-25 Years Later.

Authors:  Shelly F Greenfield; Roger D Weiss
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

4.  PTSD / substance use disorder comorbidity: Treatment options and public health needs.

Authors:  Lisa M Najavits; H Westley Clark; Carlo C DiClemente; Marc N Potenza; Howard J Shaffer; James L Sorensen; Matthew T Tull; Allen Zweben; Joan E Zweben
Journal:  Curr Treat Options Psychiatry       Date:  2020-09-24

5.  Buprenorphine substitution treatment in France: drug users' views of the doctor-user relationship.

Authors:  Anne Guichard; France Lert; Jean-Marc Brodeur; Lucie Richard
Journal:  Soc Sci Med       Date:  2007-04-17       Impact factor: 4.634

6.  Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.

Authors:  Randi Sokol; Mark Albanese; Aaronson Chew; Jessica Early; Ellie Grossman; David Roll; Greg Sawin; Dominic J Wu; Zev Schuman-Olivier
Journal:  Addict Sci Clin Pract       Date:  2019-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.